
    
      Intervention study in patients with serum vitamin D <50 nmol/l and polypharmacy, defined as
      â‰¥4 medicaments/day. Treatment duration: 6 months. Treatment groups are defined as Lm (liquid
      monthly 24'000 IU); Lw (liquid weekly 5'600 IU); Sm (solid monthly 20'000 IU) and Sw (solid
      weekly 5'600 IU). Cross-over design with identical form (liquid or solid) and switching
      frequence, i.e. from weekly to monthly treatment and vice versa, for 3 months each.
    
  